+

GB9113031D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB9113031D0
GB9113031D0 GB919113031A GB9113031A GB9113031D0 GB 9113031 D0 GB9113031 D0 GB 9113031D0 GB 919113031 A GB919113031 A GB 919113031A GB 9113031 A GB9113031 A GB 9113031A GB 9113031 D0 GB9113031 D0 GB 9113031D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB919113031A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GB919113031A priority Critical patent/GB9113031D0/en
Publication of GB9113031D0 publication Critical patent/GB9113031D0/en
Priority to EP92912277A priority patent/EP0589971A1/en
Priority to PCT/GB1992/001088 priority patent/WO1992022527A2/en
Priority to AU19750/92A priority patent/AU1975092A/en
Priority to JP4511090A priority patent/JPH06508353A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB919113031A 1991-06-17 1991-06-17 Compounds Pending GB9113031D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GB919113031A GB9113031D0 (en) 1991-06-17 1991-06-17 Compounds
EP92912277A EP0589971A1 (en) 1991-06-17 1992-06-17 Compounds
PCT/GB1992/001088 WO1992022527A2 (en) 1991-06-17 1992-06-17 3-substituted pyrrolidine derivatives as calcium channel antagonists
AU19750/92A AU1975092A (en) 1991-06-17 1992-06-17 Compounds
JP4511090A JPH06508353A (en) 1991-06-17 1992-06-17 Compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919113031A GB9113031D0 (en) 1991-06-17 1991-06-17 Compounds

Publications (1)

Publication Number Publication Date
GB9113031D0 true GB9113031D0 (en) 1991-08-07

Family

ID=10696812

Family Applications (1)

Application Number Title Priority Date Filing Date
GB919113031A Pending GB9113031D0 (en) 1991-06-17 1991-06-17 Compounds

Country Status (5)

Country Link
EP (1) EP0589971A1 (en)
JP (1) JPH06508353A (en)
AU (1) AU1975092A (en)
GB (1) GB9113031D0 (en)
WO (1) WO1992022527A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW385302B (en) * 1992-11-30 2000-03-21 Sankyo Co Alpha, omega-diarylalkane derivatives, their preparation and their use in the treatment and prevention of circulatory diseases and psychosis
GB9226111D0 (en) * 1992-12-15 1993-02-10 Smithkline Beecham Plc Madicaments
GB9314973D0 (en) * 1993-07-20 1993-09-01 Smithkline Beecham Plc Medicaments
US5849760A (en) * 1993-12-09 1998-12-15 Institut De Recherche Jouveinal 2-(arylalkenyl)azacycloalkane derivatives as ligands for sigma receptors
WO1995024390A1 (en) * 1994-03-11 1995-09-14 Smithkline Beecham Plc Novel phenyl(-alkyl/alkoxy)-1-aminoalkyl-substituted piperidines and pyrrolidines as calcium channel antagonists
GB9411052D0 (en) * 1994-06-02 1994-07-20 Smithkline Beecham Plc Medicaments
GB9411045D0 (en) * 1994-06-02 1994-07-20 Smithkline Beecham Plc Compounds and use
GB9518572D0 (en) * 1995-09-12 1995-11-15 Smithkline Beecham Plc Compounds
US5843983A (en) * 1996-02-15 1998-12-01 Sankyo Company, Limited Diphenylethane compounds containing a saturated heterocyclic group, their preparation, and their therapeutic use
HUP0104364A2 (en) * 1998-11-20 2002-04-29 F. Hoffmann-La Roche Ag. Pyrrolidine derivatives-ccr-3 receptor antagonists
GB0002100D0 (en) 2000-01-28 2000-03-22 Novartis Ag Organic compounds
BRPI0410871A (en) * 2003-05-30 2006-07-04 Neuromed Tech Inc 3-Aminomethyl pyrrolidines as n-type calcium channel blockers
ES2393632T3 (en) 2006-08-09 2012-12-26 Glaxosmithkline Llc Pyrrolidinone anilines as modulators of progesterone receptors
WO2008077089A1 (en) * 2006-12-19 2008-06-26 Smithkline Beecham Corporation Pyrrolidinanilines

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3577432A (en) * 1968-12-23 1971-05-04 Robins Co Inc A H 1-substituted-3-phenoxypyrrolidines
CA1147339A (en) * 1979-12-05 1983-05-31 Folke L. Arvidsson Phenyl-azacykloalkanes
US4785119A (en) * 1985-10-11 1988-11-15 Tokyo Kasei Kogyo Co., Ltd. 3-aminopyrrolidine compound and process for preparation thereof
DE3600390A1 (en) * 1986-01-09 1987-07-16 Hoechst Ag DIARYLALKYL-SUBSTITUTED ALKYLAMINE, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AND MEDICINAL PRODUCTS CONTAINING THE SAME
DE3614907A1 (en) * 1986-05-02 1987-11-05 Basf Ag N-SUBSTITUTED PYRROLIDONE AND PIPERIDINE DERIVATIVES AND THEIR SALTS
DE3715763A1 (en) * 1987-05-12 1988-11-24 Hoechst Ag DIARYLALKYL-SUBSTITUTED ALKYLAMINE, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AND MEDICINAL PRODUCTS CONTAINING THE SAME
DE3732930A1 (en) * 1987-09-30 1989-04-20 Basf Ag FUNGICIDAL N-SUBSTITUTED 3-ARYL-PYRROLIDINE DERIVATIVES
FR2636946B1 (en) * 1988-09-23 1990-11-02 Lipha ((DIARYLMETHOXY) ALCOYL) -1 PYRROLIDINES AND PIPERIDINES, METHODS OF PREPARATION AND MEDICAMENTS CONTAINING THEM
FR2664592B1 (en) * 1990-07-10 1994-09-02 Adir NOVEL DERIVATIVES OF PIPERIDINE, TETRAHYDROPYRIDINE AND PYRROLIDINE, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.

Also Published As

Publication number Publication date
WO1992022527A3 (en) 1993-02-18
AU1975092A (en) 1993-01-12
EP0589971A1 (en) 1994-04-06
WO1992022527A2 (en) 1992-12-23
JPH06508353A (en) 1994-09-22

Similar Documents

Publication Publication Date Title
GB9102635D0 (en) Compounds
EP0511165A3 (en) Dicetopyrrolopyrrole compounds
GB9107398D0 (en) Compounds
GB9101645D0 (en) Compounds
GB9113031D0 (en) Compounds
AP9200352A0 (en) Compounds
GB9114337D0 (en) Compounds
GB9117603D0 (en) Organophorus compounds
GB9100174D0 (en) Compounds
GB9104746D0 (en) Compounds
GB9104050D0 (en) Compounds
GB9102812D0 (en) Compounds
GB9107236D0 (en) Compounds
GB9112708D0 (en) Compounds
GB9119185D0 (en) Compounds
GB9114837D0 (en) Compounds
GB9114829D0 (en) Compounds
GB9114828D0 (en) Compounds
GB9113492D0 (en) Compounds
GB9113385D0 (en) Compounds
GB9113384D0 (en) Compounds
GB9113382D0 (en) Compounds
GB9116811D0 (en) Compounds
GB9112975D0 (en) Compounds
GB9117640D0 (en) Compounds
点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载